Back to top
Hersima 150 mg Injection
Hersima 150 mg Injection

Hersima 150 mg Injection

Hersima 150 mg Injection Specification

  • Pacakaging (Quantity Per Box)
  • One vial per box
  • Salt Composition
  • Trastuzumab 150 mg
  • Origin of Medicine
  • Biological
  • Drug Type
  • Anticancer Drug
  • Ingredients
  • Trastuzumab
  • Physical Form
  • Injection
  • Function
  • Recommended For
  • Patients with HER2-positive breast cancer or other HER2-positive cancers
  • Dosage
  • 150 mg per vial
  • Dosage Guidelines
  • Administer under the supervision of a qualified healthcare professional. Dosage and frequency depend on the patients medical condition and response to treatment.
  • Suitable For
  • Adults
  • Quantity
  • One vial per box
  • Storage Instructions
  • Store in a refrigerator at 2C to 8C. Do not freeze. Protect from light.
 
 

About Hersima 150 mg Injection



Hersima 150 mg Injection is an anticancer drug provided in the form of an injection. Each vial contains 150 mg of Trastuzumab and is suitable for adult patients with HER2-positive breast cancer or other HER2-positive tumors. It is recommended for the treatment of breast cancer, gastric cancer, and other HER2-positive cancers. The medication should be administered under healthcare professional supervision, with dosage and frequency tailored to the patients condition and response. Stored between 2-8C in a refrigerator, Hersima 150 mg Injection must be protected from light and should not be frozen.

FAQs of Hersima 150 mg Injection:


Q: What is Hersima 150 mg Injection used for?

A: Hersima 150 mg Injection is used in the treatment of breast cancer, gastric cancer, and other HER2-positive tumors.

Q: How should Hersima 150 mg Injection be stored?

A: Hersima 150 mg Injection should be stored in a refrigerator between 2-8C, protected from light, and should not be frozen.

Q: Who is Hersima 150 mg Injection suitable for?

A: Hersima 150 mg Injection is suitable for adults with HER2-positive breast cancer or other HER2-positive cancers.

Q: What is the dosage guideline for Hersima 150 mg Injection?

A: Hersima 150 mg Injection should be administered under the supervision of a qualified healthcare professional, with dosage and frequency dependent on the patients medical condition and response to treatment.

Q: What are the main ingredients of Hersima 150 mg Injection?

A: The main ingredient of Hersima 150 mg Injection is Trastuzumab, with each vial containing 150 mg of Trastuzumab.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

Enzyl 40 mg Capsule

Enzyl 40 mg Capsule

Origin of Medicine : Synthetic

Suitable For : Adults

Recommended For : Individuals with digestive issues

Physical Form : Other, Capsule

Salt Composition : Pancreatin or other enzyme combination (specific composition varies by manufacturer)

Dosage Guidelines : Take as directed by a healthcare professional

Lipodox 10 mg Injection

Lipodox 10 mg Injection

Origin of Medicine : Allopathic

Suitable For : Adults

Recommended For : Cancer patients including those with breast cancer ovarian cancer or Kaposis sarcoma

Physical Form : Other, Injection

Salt Composition : Doxorubicin Hydrochloride Liposomal

Dosage Guidelines : Administered as per physicians prescription under medical supervision

Kadcyla 100 mg Injection

Kadcyla 100 mg Injection

Origin of Medicine : Biological

Suitable For : Adults

Recommended For : Patients with HER2positive metastatic breast cancer

Physical Form : Other, Injection

Salt Composition : Trastuzumab Emtansine

Dosage Guidelines : Administered intravenously under the supervision of a healthcare professional

Zoldonat 4 mg Injection

Zoldonat 4 mg Injection

Origin of Medicine : Allopathic

Suitable For : Adults

Recommended For : Patients with bonerelated conditions such as osteoporosis or bone metastasis

Physical Form : Liquid

Salt Composition : Zoledronic Acid 4 mg

Dosage Guidelines : Administered intravenously under the supervision of a healthcare professional